BIOMAT Database Logo BIOMAT Database Logo

Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors. 2007

Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Cancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA. Zhi-Fu.Tao@abbott.com

An extensive structure-activity relationship study of the 3-position of a series of tricyclic pyrazole-based Chk1 inhibitors is described. As a result, 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles (4) and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles (29) emerged as new lead series. Compared with the original lead compound 2, these new leads fully retain the biological activity in both enzymatic inhibition and cell-based assays. More importantly, the new leads 4 and 29 exhibit favorable physicochemical properties such as lower molecular weight, lower Clog P, and the absence of a hydroxyl group. Furthermore, structure-activity relationship studies were performed at the 6- and 7-positions of 4, which led to the identification of ideal Chk1 inhibitors 49, 50, 51, and 55. These compounds not only potently inhibit Chk1 in an enzymatic assay but also significantly potentiate the cytotoxicity of DNA-damaging agents in cell-based assays while they show little single agent activity. A cell cycle analysis by FACS confirmed that these Chk1 inhibitors efficiently abrogate the G2/M and S checkpoints induced by DNA-damaging agent. The current work paved the way to the identification of several potent Chk1 inhibitors with good pharmacokinetics that are suitable for in vivo study with oral dosing.

UI MeSH Term Description Entries
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D000071877 Checkpoint Kinase 1 A serine/threonine-specific protein kinase which is encoded by the CHEK1 gene in humans. Checkpoint kinase 1 (also known as Chk1) coordinates DNA damage response and cell cycle checkpoint response. Under these conditions, activation of Chk1 results in the initiation of cell cycle checkpoints, cell cycle arrest, DNA repair and cell death, to prevent damaged cells from progressing through the cell cycle. Checkpoint-1 Kinase,Chk1 Kinase,Chk1 Protein Kinase,Protein Kinase, Chk1
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides.
December 2016, Journal of enzyme inhibition and medicinal chemistry,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors.
April 2007, Bioorganic & medicinal chemistry,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Diethyl 4-[2-(4-meth-oxy-phen-yl)-1H-pyrazol-3-yl]-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ate.
June 2011, Acta crystallographica. Section E, Structure reports online,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Dimethyl 2,6-dimethyl-4-(3-phenyl-1H-pyrazol-4-yl)-1,4-dihydro-pyridine-3,5-dicarboxyl-ate.
April 2012, Acta crystallographica. Section E, Structure reports online,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Dimethyl 4-[3-(4-meth-oxy-phen-yl)-1-phenyl-1H-pyrazol-4-yl]-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxyl-ate dihydrate.
July 2012, Acta crystallographica. Section E, Structure reports online,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
September 2015, Bioorganic & medicinal chemistry letters,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Dimethyl 2,6-dimethyl-4-{3-[4-(methyl-sulfan-yl)phen-yl]-1H-pyrazol-4-yl}-1,4-dihydro-pyridine-3,5-dicarboxyl-ate monohydrate.
December 2012, Acta crystallographica. Section E, Structure reports online,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.
November 2008, Journal of medicinal chemistry,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Discovery of 3-Chloro-N-{(S)-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl][(2S)-piperidine-2-yl]methyl}-4-(trifluoromethyl)pyridine-2-carboxamide as a Potent Glycine Transporter 1 Inhibitor.
January 2016, Chemical & pharmaceutical bulletin,
Zhi-Fu Tao, and Gaoquan Li, and Yunsong Tong, and Kent D Stewart, and Zehan Chen, and Mai-Ha Bui, and Philip Merta, and Chang Park, and Peter Kovar, and Haiying Zhang, and Hing L Sham, and Saul H Rosenberg, and Thomas J Sowin, and Nan-Horng Lin
Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors.
April 2016, Archives of pharmacal research,
Copied contents to your clipboard!